Laboratory Testing and Risk Classification
Historically, insurers in North America have been collecting and analyzing urine specimens form proposed insureds since the early 1900s. In this manner, they identified unknown or unreported diabetes and renal diseases — thereby allowing the more accurate classification of risk. Much later, blood testing was added to identify earlier stages of glucose intolerance, liver disease, renal disease, antibodies to HIV, and lipid abnormalities. More recently, oral fluid testing was developed to test for HIV antibodies, cocaine, and cotinine. As insurance policy design has evolved with different premium rates for tobacco and non-tobacco users and preferred risk categories, laboratory testing has assumed a greater role in the classification of risk.
KeywordsCholesterol Obesity Hepatitis Creatinine Morphine
Unable to display preview. Download preview PDF.
- 1.Sasse EA. In: Kaplan LA, Pesce AJ, Kazmierczak SC (eds). Clinical Chemistry: Theory, Analysis, Correlation. St. Louis, MO, 2003, Mosby.Google Scholar
- 4.Smith C. Life Insurance Today: An Actuary’s View. J Ins Med 1988; 20: 7–11.Google Scholar
- 5.Braun RE. Screening tests: why, which ones, and when? Med Resource 1990; 2: 4–6.Google Scholar
- 7.Titcomb C. Protective value holds key to testing issue. Med Resource 2001; 13: 8.Google Scholar
- 8.Bachorik PS et al. In: Henry JB (ed) Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, PA, 2001, W.B. Saunders Company.Google Scholar